Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > CEA-Leti Announces TARGET-PDT Study Aimed at Improving Photodynamic Therapy for Cancer Treatment

Abstract:
CEA-Leti today announced the launch of the TARGET-PDT project designed to increase the effectiveness of photodynamic therapy (PDT) for treating cancer by developing a novel nano carrier-based approach.

CEA-Leti Announces TARGET-PDT Study Aimed at Improving Photodynamic Therapy for Cancer Treatment

Grenoble, France | Posted on May 11th, 2010

PDT is a minimally invasive treatment that destroys cancer cells with a combination of a photoactive drug known as a photosensitizer and a specific wavelength of light. When the photosensitizers are activated by the laser light, they produce a form of oxygen that destroys illuminated cancer cells.

Focusing on using PDT against bone cancer and head-and-neck squamous cell carcinoma, which is a tumor e.g. of the oral cavity, the project will study the delivery and targeting of photosensitizers encapsulated into lipid nano-particles. For both cancer forms, current treatment regimes often result in low cure rates and show serious side effects or a poor functional outcome. The nano-carriers offer a high payload that will include antibodies targeting specific tumor biomarkers.

PDT has already shown significant potential for improving cancer treatment because it offers strictly focused application, biocompatibility with other forms of treatment, the option for repeated use, excellent cosmetic or functional outcomes and fast recovery. Indeed, typically there is a modest enhanced accumulation of the photosensitizer in tumor tissues and an additional selectivity is mainly provided by the confined illumination of the target area.

But, the use of PDT has been restrained by limited effectiveness of the photosensitizers on reaching the tumor and the potential damage to healthy cells near the tumor. Improved targeting of the photosensitizer and nano-particles is necessary to prevent damage to the surrounding healthy tissue.

CEA-Leti, which is coordinating this European project, expects the nano carrier-based approach will significantly improve delivery and targeting of the photosensitizer, enhancing concentrations at the tumor site even after systemic application.

The TARGET-PDT project will allow the partners to study all aspects of PDT treatment: nano-carrier size and payload, photosensitizers such as chlorines and phthalocyanines, targeting method and types of laser irradiation.

The experimental approach will be developed into a preclinical validation to deliver an optimised combination for first clinical "nano-PDT" at a later stage. By using nanotechnology-based photosensitizer delivery systems, the project will set the stage for improved control of the therapy and more comfort for cancer patients.

####

About CEA-Leti
CEA is a French research and technology public organisation, with activities in four main areas: energy, information technologies and healthcare technologies, defence and security. Within CEA, the Laboratory for Electronics & Information Technology (CEA-Leti) works with companies in order to increase their competitiveness through technological innovation and transfers. CEA-Leti is focused on micro and nanotechnologies and their applications, from wireless devices and systems, to biology and healthcare or photonics.

Nanoelectronics and microsystems (MEMS) are at the core of its activities. As a major player in MINATEC excellence center, CEA-Leti operates 8,000-m state-of-the-art clean rooms, on 24/7 mode, on 200mm and 300mm wafer standards. With 1,200 employees, CEA-Leti trains more than 150 Ph.D. students and hosts 200 assignees from partner companies. Strongly committed to the creation of value for the industry, CEA-Leti puts a strong emphasis on intellectual property and owns more than 1,400 patent families. In 2008, contractual income covered more than 75 percent of its budget worth 205 M. For more information, visit www.leti.fr.

About TARGET-PDT
CEA-Leti is coordinating TARGET-PDT as part of its research program on organic nanocarriers and delivery systems for clinical applications like molecular imaging and drug delivery.

The partnership includes highly complementary partners. In addition to CEA-Leti, they are the European industrial leader in PDT, the German company biolitec AG; University Hospital Zurich, which is recognized for it clinical PDT capabilities; French academic laboratories belonging to the Centre National de la Recherche Scientifique (CNRS) and the Anticancer Research Center; and Centre Alexis Vautrin in Nancy, France, which specializes in PDT from bench to bedside.

For more information, please click here

Contacts:
Technical contact:
Patrick Boisseau, project coordinator
+33 4 38 78 38 54


Press contacts:
CEA-Leti
Thierry Bosc
+33 4 38 78 31 95


Agency
Sarah-Lyle Dampoux
+33 1 58 18 59 30

Copyright © CEA-Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Quantum teleportation on a chip: A significant step towards ultra-high speed quantum computers April 1st, 2015

So, near and yet so far: Stable HGNs for Raman April 1st, 2015

Two-dimensional dirac materials: Structure, properties, and rarity April 1st, 2015

3-D neural structure guided with biocompatible nanofiber scaffolds and hydrogels April 1st, 2015

Possible Futures

Nanotechnology in Medical Devices Market is expected to reach $8.5 Billion by 2019 March 25th, 2015

Nanotechnology Enabled Drug Delivery to Influence Future Diagnosis and Treatments of Diseases March 21st, 2015

Nanocomposites Market Growth, Industry Outlook To 2020 by Grand View Research, Inc. March 21st, 2015

Nanotechnology Drug Delivery Market in the US 2012-2016 : Latest Report Available by Radiant Insights, Inc March 16th, 2015

Nanomedicine

A novel way to apply drugs to dental plaque Nanoparticles release drugs to reduce tooth decay April 1st, 2015

3-D neural structure guided with biocompatible nanofiber scaffolds and hydrogels April 1st, 2015

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Announcements

Quantum teleportation on a chip: A significant step towards ultra-high speed quantum computers April 1st, 2015

So, near and yet so far: Stable HGNs for Raman April 1st, 2015

Two-dimensional dirac materials: Structure, properties, and rarity April 1st, 2015

3-D neural structure guided with biocompatible nanofiber scaffolds and hydrogels April 1st, 2015

Nanobiotechnology

3-D neural structure guided with biocompatible nanofiber scaffolds and hydrogels April 1st, 2015

From tobacco to cyberwood March 31st, 2015

Wrapping carbon nanotubes in polymers enhances their performance: Scientists at Japan's Kyushu University say polymer-wrapped carbon nanotubes hold much promise in biotechnology and energy applications March 30th, 2015

'Atomic chicken-wire' is key to faster DNA sequencing March 30th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE